GM1bCer (d20:1/24:1) is a sialic-acid-containing glycosphingolipid and can be used as a validated standard in the research of tumor-specific antigen screening.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.